摘要:
A hard-coated antiglare film that has superior antiglare properties, allow high definition to be provided even in the case of a low haze value, can prevent white blur in an oblique direction from occurring and, and can improve the depth of black in black display, as well as a polarizing plate, and the like. The hard-coated antiglare film includes a transparent plastic film substrate and a hard-coating antiglare layer containing fine particles, which is on at least one surface of the transparent plastic film substrate. The hard-coated antiglare film has a total haze value Ht in the range of 10% to 35%. The total haze value Ht and an internal haze value Hin satisfy a relationship of 0.5≦Hin/Ht≦0.9. The surface of the hard-coating antiglare layer has an uneven shape and an arithmetic average surface roughness Ra in the range of 0.1 to 0.3 μm. The hard-coated antiglare film includes: convexities that exceed a roughness mean line of a surface roughness profile; no convexities in which line segments of portions of the mean line that cross the convexities each have a length of 80 μm or longer, and convexities that exceed a standard line that is in parallel with the mean line and is located at a height of 0.1 μm; and at least 50 convexities in which line segments of portions of the standard line that cross the convexities each have a length of 20 μm or shorter in 4-mm long portion at an arbitrary location of the surface of the hard-coating antiglare layer.
摘要:
The present invention relates to a benzenesulfonamide derivative of formula (I), which is useful as an active ingredient of pharmaceutical preparations. The benzenesulfonamide derivatives of the present invention have CCR3 (CC type chemokine receptor) antagonistic activity, and can be used for the prophylaxis and treatment of diseases associated with CCR3 activity, in particular for the treatment of asthma, atopic dermatitis, allergic rhinitis and other inflammatory/immunological disorders. In said formula, X represents O or S; R4 represents formulae (a), (b), (c), (d), (e), (f), (g), (h), (i) or (j), the other substituents are as defined in claim 1.
摘要:
The invention relates to Substituted-Quinoxaline-Type Piperidine Compounds, compositions comprising an effective amount of a Substituted-Quinoxaline-Type Piperidine Compound and methods to treat or prevent a condition, such as pain, comprising administering to an animal in need thereof an effective amount of a Substituted-Quinoxaline-Type Piperidine Compound.
摘要:
A hard-coated antiglare film, comprising a transparent plastic film substrate and a hard-coating antiglare layer containing fine particles on at least one surface of the transparent plastic film substrate, wherein an arithmetic average surface roughness Ra (μm) that is defined in JIS B 0601 (1994 version) is in the range of 0.05 to 0.15 μm in an uneven shape of a surface of the hard-coating antiglare layer, and the hard-coated antiglare film includes at least 80 convexities that exceed a roughness mean line of a surface roughness profile in a 4-mm long portion at an arbitrary location of the surface of the hard-coating antiglare layer.
摘要翻译:一种硬涂层的防眩膜,其包含透明塑料膜基材和在透明塑料膜基材的至少一个表面上含有微粒的硬涂层防眩层,其中在JIS中定义的算术平均表面粗糙度Ra(μm) B 0601(1994版)在硬涂层防眩光层的表面的不均匀形状中为0.05〜0.15μm的范围,硬涂层的防眩光膜包括至少80个超过粗糙度平均线的凸面 在硬涂层防眩光层的表面的任意位置处的4mm长的部分中的表面粗糙度轮廓。
摘要:
Provided herein are 2-phenoxy- and 2-phenylsulfonamide derivatives with CCR3 antagonistic activity. These compounds are useful for the treatment of diseases associated with CCR3 activity, including but not limited to, atopic dermatitis, allergic rhinitis, rheumatoid arthritis, Grave's disease, HIV infection, Alzheimer's disease, atherosclerosis and other inflammatory and/or immunological disorders.
摘要:
The disclosure relates to Substituted Piperidin-4-amino-Type Compounds of Formula (I) and pharmaceutically acceptable salts and solvates thereof wherein R1, R2, R3, Q1, Q2, E1, E2, A, B, D, W, Z, a, b, n, and x are as defined herein, compositions comprising an effective amount of a Substituted Piperidin-4-amino-Type Compound, and methods to treat or prevent a condition, such as pain, comprising administering to an animal in need thereof an effective amount of a Substituted Piperidin-4-amino-Type Compound.
摘要:
A hard-coated antiglare film that has superior antiglare properties, allow high definition to be provided even in the case of a low haze value, can prevent white blur in an oblique direction from occurring and, and can improve the depth of black in black display, as well as a polarizing plate, and the like. The hard-coated antiglare film includes a transparent plastic film substrate and a hard-coating antiglare layer containing fine particles, which is on at least one surface of the transparent plastic film substrate. The hard-coated antiglare film has a total haze value Ht in the range of 10% to 35%. The total haze value Ht and an internal haze value Hin satisfy a relationship of 0.5≦Hin/Ht≦0.9. The surface of the hard-coating antiglare layer has an uneven shape and an arithmetic average surface roughness Ra in the range of 0.1 to 0.3 μm.
摘要翻译:具有优异防眩性的硬涂层防眩膜即使在低雾度值的情况下也能够提供高清晰度,可以防止发生倾斜方向的白色模糊,并且可以改善黑色显示中的黑色深度 ,以及偏振片等。 硬涂层的防眩膜包括透明塑料膜基材和在透明塑料膜基材的至少一个表面上的含有微粒的硬涂层防眩光层。 硬涂层防眩膜的总浊度值Ht在10%至35%的范围内。 总雾度值Ht和内部雾度值Hin满足0.5≦̸ Hin / Ht≦̸ 0.9的关系。 硬涂层防眩层的表面具有不均匀的形状和算术平均表面粗糙度Ra在0.1至0.3μm的范围内。
摘要:
Compounds of Formula (I): where R1, R2, R5, a, and b are disclosed herein, and pharmaceutically acceptable derivatives thereof (a “Substituted-Quinoxaline-Type Bridged-Piperidine Compound”), compositions comprising an effective amount of a Substituted-Quinoxaline-Type Bridged-Piperidine Compound, and methods to treat or prevent a condition, such as pain, comprising administering to an animal in need thereof an effective amount of a Substituted-Quinoxaline-Type Bridged-Piperidine Compound.
摘要:
The invention relates to Heterocyclic-Substituted Piperidine Compounds, compositions comprising an effective amount of a Heterocyclic-Substituted Piperidine Compound and methods to treat or prevent a condition, such as pain, comprising administering to an animal in need thereof an effective amount of a Heterocyclic-Substituted Piperidine Compound.
摘要:
The disclosure relates to Substituted Piperidin-4-amino-Type Compounds of Formula (I) and pharmaceutically acceptable salts and solvates thereof wherein R1, R2, R3, Q1, Q2, E1, E2, A, B, D, W, Z, a, b, n, and x are as defined herein, compositions comprising an effective amount of a Substituted Piperidin-4-amino-Type Compound, and methods to treat or prevent a condition, such as pain, comprising administering to an animal in need thereof an effective amount of a Substituted Piperidin-4-amino-Type Compound.